tiprankstipranks
Advertisement

RINT - ETF AI Analysis

Compare

Top Page

RINT

International Developed Equity Active ETF (RINT)

Rating:65Neutral
Price Target:
RINT’s rating suggests it is a solid but not top-tier international developed markets ETF, supported by several high-quality companies. Strong holdings like TSM, HSBC, AstraZeneca, Novartis, and GlaxoSmithKline boost the fund through solid financial performance, positive earnings sentiment, and strategic growth initiatives, especially in healthcare and advanced technology. However, some holdings such as Schneider Electric and names with valuation or technical concerns introduce risk, and the fund’s notable exposure to financials and healthcare means performance could be sensitive to sector-specific challenges.
Positive Factors
Solid Recent Performance
The ETF has shown strong gains so far this year and over the past month, indicating positive recent momentum.
Global Developed Market Diversification
Holdings spread across many developed countries such as Japan, the U.S., the UK, and major European markets help reduce reliance on any single economy.
Strong Leading Holdings in Key Industries
Top positions like ASML, TSMC, and Shell have delivered strong year-to-date results, supporting the fund’s overall performance.
Negative Factors
Moderate Expense Ratio
The fund’s fee is higher than many low-cost index ETFs, which can slightly reduce long-term returns.
Mixed Performance Among Top Holdings
Several large positions, including SAP, UBS, Roche, and AstraZeneca, have shown weaker or negative year-to-date performance, which can drag on the fund.
Financial Sector and Country Concentration
Meaningful exposure to financials and heavier weights in a few countries like Japan, the U.S., and the UK increase sensitivity to downturns in those areas.

RINT vs. SPDR S&P 500 ETF (SPY)

RINT Summary

RINT is an actively managed ETF that invests in stocks from developed countries outside the U.S., aiming for long-term growth. It doesn’t track a fixed index, but instead uses professional managers to pick a wide mix of companies across many sectors and countries like Japan, the UK, and Europe. Well-known holdings include chip maker TSMC and healthcare giant Novartis. Someone might invest in RINT to diversify beyond the U.S. stock market and tap into growth in other developed economies. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, with professionals selecting and adjusting the fund’s holdings instead of simply tracking an index.
What would affect this ETF?This ETF could benefit if developed markets outside the U.S. grow steadily, especially in financials, industrials, and global technology leaders like ASML and TSMC, and if international stocks come back into favor as investors look to diversify beyond the U.S. It could face challenges from global slowdowns, banking or energy sector stress, stronger regulations or taxes in Europe and other regions, or rising interest rates that hurt stock prices in its major markets.

RINT Top 10 Holdings

RINT is leaning heavily on global semiconductors, with ASML and TSMC acting as the fund’s main growth engines, both rising on the back of strong demand for advanced chips and AI-related hardware. Financial heavyweights like UBS and HSBC are also pulling their weight, offering steady gains and helping anchor the portfolio. On the flip side, big pharma names such as AstraZeneca and Roche have been lagging, losing a bit of steam and softening overall returns. The fund is firmly ex-U.S., giving investors a diversified slice of developed international markets.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV1.96%$2.29M€624.32B122.09%
76
Outperform
TSMC1.49%$1.74M$1.98T98.28%
81
Outperform
Shell (UK)1.31%$1.53M£160.46B15.63%
73
Outperform
UBS Group AG1.15%$1.34M$154.91B46.26%
73
Outperform
HSBC Holdings1.03%$1.20M£249.33B62.95%
80
Outperform
AstraZeneca1.02%$1.19M$300.37B37.99%
80
Outperform
Roche Holding AG0.99%$1.16M$337.33B25.57%
73
Outperform
Schneider Electric0.95%$1.11M€157.76B23.85%
62
Neutral
Novartis AG0.95%$1.10MCHF233.53B28.16%
80
Outperform
GlaxoSmithKline0.90%$1.05M£80.71B42.10%
77
Outperform

RINT Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
31.51
Positive
100DMA
30.85
Positive
200DMA
29.87
Positive
Market Momentum
MACD
0.15
Negative
RSI
56.10
Neutral
STOCH
57.37
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RINT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 31.87, equal to the 50-day MA of 31.51, and equal to the 200-day MA of 29.87, indicating a bullish trend. The MACD of 0.15 indicates Negative momentum. The RSI at 56.10 is Neutral, neither overbought nor oversold. The STOCH value of 57.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RINT.

RINT Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$144.62M0.49%
65
Neutral
$647.46M0.59%
60
Neutral
$516.74M0.65%
64
Neutral
$477.72M0.23%
65
Neutral
$236.20M0.29%
69
Neutral
$174.19M0.30%
62
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RINT
International Developed Equity Active ETF
32.14
5.60
21.10%
FYLD
Cambria Foreign Shareholder Yield ETF
TXUE
Thornburg International Equity ETF
AVSD
Avantis Responsible International Equity ETF
NBIE
Neuberger International Core Equity ETF
DXIV
Dimensional International Vector Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement